Cargando…

Prednisone reduction for metastatic castration-resistant prostate cancer with recurrent pulmonary tuberculosis: Case report

INTRODUCTION: Prednisone (10 mg/d) is often used in combination with docetaxel or abiraterone in the treatment of advanced prostate cancer. LATITUDE studies have confirmed that the combination of abiraterone and prednisone (5 mg/d) can be used for the treatment of newly diagnosed high-risk metastati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Xiaojuan, Shi, Zhenguo, Gao, Shegan, Wang, Xiaohong, Wang, Pei, Kang, Chongzhao, Zhao, Fangzong, Hou, Peng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	7300
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8052077/ https://www.ncbi.nlm.nih.gov/pubmed/33847689 http://dx.doi.org/10.1097/MD.0000000000025584

Ejemplares similares

Treatment outcomes with radium-223 in docetaxel-naïve versus docetaxel-treated metastatic castration-resistant prostate cancer patients: Real-world evidence from Taiwan
por: Chiang, Ping-Chia, et al.
Publicado: (2023)

Post hoc analyses of East Asian patients from the randomized placebo-controlled PREVAIL trial of enzalutamide in patients with chemotherapy-naïve, metastatic castration-resistant prostate cancer
por: Kim, Choung Soo, et al.
Publicado: (2017)

Chemotherapy with or without estramustine for treatment of castration-resistant prostate cancer: A systematic review and meta-analysis
por: Qin, Zhiqiang, et al.
Publicado: (2016)

Efficacy and safety of abiraterone and enzalutamide for castration-resistant prostate cancer: A systematic review and meta-analysis of randomized controlled trials
por: Zheng, Xiaonan, et al.
Publicado: (2019)

Prostate tuberculosis mimicking prostate cancer: Case report and literature review
por: Li, Yu, et al.
Publicado: (2023)

Development and validation of a SEER-based prognostic nomogram for patients with bone metastatic prostate cancer
por: Hou, Guangdong, et al.
Publicado: (2019)

Reactivation of latent tuberculosis infection induced by cabazitaxel in a patient with prostate cancer: A case report
por: Hashimoto, Mamoru, et al.
Publicado: (2019)

Pretreatment Neutrophil-to-Lymphocyte Ratio: A Predictor of Advanced Prostate Cancer and Biochemical Recurrence in Patients Receiving Radical Prostatectomy
por: Zhang, Gui-Ming, et al.
Publicado: (2015)

Upregulation of Talin-1 expression associates with advanced pathological features and predicts lymph node metastases and biochemical recurrence of prostate cancer
por: Xu, Ning, et al.
Publicado: (2016)

Genetic variants of the CYP1B1 gene as predictors of biochemical recurrence after radical prostatectomy in localized prostate cancer patients
por: Gu, Cheng-Yuan, et al.
Publicado: (2016)

Novel survival nomograms for patients with lung metastatic clear cell renal cell carcinoma: A population-based study
por: Zhang, Lei, et al.
Publicado: (2020)

Relationship of oestrogen receptor alpha gene polymorphisms with risk for benign prostatic hyperplasia and prostate cancer in Chinese men
por: Han, Zihua, et al.
Publicado: (2017)

Contrast-enhanced ultrasound targeted versus conventional ultrasound guided systematic prostate biopsy for the accurate diagnosis of prostate cancer: A meta-analysis
por: Zhang, Ming, et al.
Publicado: (2022)

Value of free/total prostate-specific antigen (f/t PSA) ratios for prostate cancer detection in patients with total serum prostate-specific antigen between 4 and 10 ng/mL: A meta-analysis
por: Huang, Yan, et al.
Publicado: (2018)

The application of IL-10 and TNF-α in expressed prostatic secretions and prostatic exosomal protein in urine in the diagnosis of patients with chronic prostatitis
por: Yin, Lianli, et al.
Publicado: (2019)

Transurethral 1470 nm diode laser vaporization versus plasma kinetic enucleation of the prostate for the treatment of benign prostatic hyperplasia: A retrospective study
por: Huang, Jiaguo, et al.
Publicado: (2023)

Can bipolar transurethral enucleation of the prostate be a better alternative to the bipolar transurethral resection of the prostate?: A prospective comparative study
por: Abdulwahab Al-radhi, Mohammed, et al.
Publicado: (2021)

Lycopene and Risk of Prostate Cancer: A Systematic Review and Meta-Analysis
por: Chen, Ping, et al.
Publicado: (2015)

The establishment and evaluation of a new model for the prediction of prostate cancer
por: Wang, Qi, et al.
Publicado: (2017)

Feasibility of anterior lobe-preserving transurethral enucleation and resection of prostate on improving urinary incontinence in patients with benign prostatic hyperplasia: A retrospective cohort study
por: Huang, Xin, et al.
Publicado: (2023)

ESR2 polymorphisms on prostate cancer risk: A systematic review and meta-analysis
por: Chang, Xueliang, et al.
Publicado: (2023)

The first case of bipolar transurethral resection of the prostate for giant prostatic hyperplasia: A case report
por: Cui, Deheng, et al.
Publicado: (2022)

Radiation dose of prostatic artery embolization for benign prostatic hyperplasia: A protocol for systematic review
por: Liu, Jinglei, et al.
Publicado: (2022)

Identification of novel biomarkers correlated with prostate cancer progression by an integrated bioinformatic analysis
por: Ma, Zhifang, et al.
Publicado: (2020)

Long-term maintenance treatment of recurrent ureteropelvic junction obstruction with covered metallic ureteral stent
por: Tang, Xinwei, et al.
Publicado: (2023)

Benign Prostatic Hyperplasia and the Risk of Prostate Cancer and Bladder Cancer: A Meta-Analysis of Observational Studies
por: Dai, Xiaoyu, et al.
Publicado: (2016)

Absence of Bladder Outlet Obstruction Is an Independent Risk Factor for Prostate Cancer in Men Undergoing Prostate Biopsy
por: Cormio, Luigi, et al.
Publicado: (2016)

Effect of prostate volume on the peripheral nerve block anesthesia in the prostate biopsy: A strobe-compliant study
por: Luan, Yang, et al.
Publicado: (2016)

Is targeted biopsy really needed when performing systematic prostate biopsy to raise the detection rate for prostate cancer in patients with prostate-specific antigen ≤10 ng/mL?
por: Park, Jee Soo, et al.
Publicado: (2019)

Microarray analysis of copy-number variations and gene expression profiles in prostate cancer
por: Han, Yuping, et al.
Publicado: (2017)

The Relationship Between the Adverse Events and Efficacy of Sorafenib in Patients With Metastatic Renal Cell Carcinoma: A Multicenter Retrospective Study from Northwest China
por: Zheng, Yu, et al.
Publicado: (2015)

Primary synovial sarcoma and acinar adenocarcinoma of prostate rarely occur simultaneously: A case report
por: Shi, Qichong, et al.
Publicado: (2023)

Green tea and the risk of prostate cancer: A systematic review and meta-analysis
por: Guo, Yuming, et al.
Publicado: (2017)

Single-cell and bulk RNA sequencing reveal cancer-associated fibroblast heterogeneity and a prognostic signature in prostate cancer
por: Liu, Wen, et al.
Publicado: (2023)

The Influence of Prednisone on the Efficacy of Docetaxel in Men with Metastatic Castration-Resistant Prostate Cancer
por: Teply, Benjamin A., et al.
Publicado: (2015)

The Influence of Prednisone on the Efficacy of Cabazitaxel in Men with Metastatic Castration-Resistant Prostate Cancer
por: Buonerba, Carlo, et al.
Publicado: (2017)

Traditional Chinese medicine on treating pain caused by prostate cancer: A systematic review and meta-analysis
por: Wang, Ning, et al.
Publicado: (2019)

Smoking habits and benign prostatic hyperplasia: A systematic review and meta-analysis of observational studies
por: Xu, Huan, et al.
Publicado: (2016)

Diagnosis and treatment of gastrointestinal stromal tumor extending to prostate: A case report and literature review
por: Xu, Huan, et al.
Publicado: (2016)

Comprehensive analysis of biomarkers for prostate cancer based on weighted gene co-expression network analysis
por: Chen, Xuan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jbuek3m4fog1bgqngackjo0u4r